β-catenin as a regulator and therapeutic target for asthmatic airway remodeling.
about
Identification of potential COPD genes based on multi-omics data at the functional level.The effects of in utero vitamin D deficiency on airway smooth muscle mass and lung function.MiR-3162-3p Is a Novel MicroRNA That Exacerbates Asthma by Regulating β-Catenin.Eosinophils enhance WNT-5a and TGF-β1 genes expression in airway smooth muscle cells and promote their proliferation by increased extracellular matrix proteins production in asthma.Hyperinsulinemia adversely affects lung structure and function.Noncanonical WNT-5A signaling impairs endogenous lung repair in COPDTranscriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle.The roles and regulation of the actin cytoskeleton, intermediate filaments and microtubules in smooth muscle cell migration.Knockdown of β-catenin by siRNA influences proliferation, apoptosis and invasion of the colon cancer cell line SW480Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.An Official American Thoracic Society Research Statement: Current Challenges Facing Research and Therapeutic Advances in Airway Remodeling.'WNT-er is coming': WNT signalling in chronic lung diseases.Blockade of β-catenin signaling attenuates toluene diisocyanate-induced experimental asthma.The receptor for advanced glycation end products is required for β-catenin stabilization in a chemical-induced asthma model.Selective targeting of CREB-binding protein/β-catenin inhibits growth of and extracellular matrix remodelling by airway smooth muscle.Expression of DACT1 in children with asthma and its regulation mechanism.Tiotropium inhibits methacholine-induced extracellular matrix production via β-catenin signaling in human airway smooth muscle cells.
P2860
Q31024506-17D582C2-F745-43BA-91D7-861DD2BA60BEQ34471398-86116CA0-1135-46AF-8BA3-60578831F209Q35951046-23CE6D59-A61A-459F-BE41-718A9DA4A576Q36051226-7E069991-5CF6-4974-9C36-DC38752519ABQ36902404-A166B881-3CA9-4AEE-A587-C6B32BB2ABDFQ37549718-94D67CCE-CF08-4862-9C94-C2AC266AED39Q37682717-4DF02332-1110-42C6-9C0F-04D5760A87E1Q37742401-8628A548-41EC-441D-8030-BBC9975B053EQ38763967-230B0035-F49A-423D-91EB-75983BD97E29Q38811516-11F41767-EAF0-4964-8622-6EEC9FB65B40Q39085502-416EF32C-EB94-4A0F-BF40-A3125545BA88Q39247047-624F291F-0FD6-4AB1-87E8-55AE3369DF42Q39614255-3AA920F4-94C4-4951-93D3-A8ACB206DC7AQ39614262-97A4A67D-AA00-4F01-8248-A5E91077C66DQ40485763-5DFBF3ED-E7D0-4439-8564-98B15140EB18Q49875821-B25CA980-EBB1-46DD-8623-EB80993DEAFEQ54979017-13B284F0-C0D7-4EEC-85A6-B22E02650488
P2860
β-catenin as a regulator and therapeutic target for asthmatic airway remodeling.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
β-catenin as a regulator and therapeutic target for asthmatic airway remodeling.
@en
type
label
β-catenin as a regulator and therapeutic target for asthmatic airway remodeling.
@en
prefLabel
β-catenin as a regulator and therapeutic target for asthmatic airway remodeling.
@en
P2093
P2860
P1476
β-catenin as a regulator and therapeutic target for asthmatic airway remodeling.
@en
P2093
Kuldeep Kumawat
Reinoud Gosens
Tim Koopmans
P2860
P304
P356
10.1517/14728222.2014.934813
P407
P577
2014-07-08T00:00:00Z